Abstract
Angelman syndrome (AS) is a rare genetic neurogenetic disorder causing developmental delays, speech impairments, movement disorder, and behavioral abnormalities. Systematic literature reviews (SLRs) were designed to summarize the evidence base and understand data gaps related to: (1) assessments of health-related quality of life (HRQoL) and health utility, and (2) healthcare resource utilization (HCRU) and/or costs associated with AS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
